FDA Finalizes Guidance on Product Name Placement in Advertisements

Drug Industry Daily
The FDA finalized its guidance on drug advertisements, clarifying the legal requirements for companies in the placement of the product’s name — as well as its size, prominence and frequency in promotional labeling, and the juxtaposition between branded and active ingredient names.

To View This Article:


Subscribe To Drug Industry Daily